GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Benchmark Holdings PLC (LSE:BMK) » Definitions » Cash Conversion Cycle

Benchmark Holdings (LSE:BMK) Cash Conversion Cycle : 168.16 (As of Dec. 2023)


View and export this data going back to 2013. Start your Free Trial

What is Benchmark Holdings Cash Conversion Cycle?

Cash Conversion Cycle is one of several measures of management effectiveness. It equals Days Sales Outstanding + Days Inventory - Days Payable.

Benchmark Holdings's Days Sales Outstanding for the three months ended in Dec. 2023 was 91.57.
Benchmark Holdings's Days Inventory for the three months ended in Dec. 2023 was 200.75.
Benchmark Holdings's Days Payable for the three months ended in Dec. 2023 was 124.16.
Therefore, Benchmark Holdings's Cash Conversion Cycle (CCC) for the three months ended in Dec. 2023 was 168.16.


Benchmark Holdings Cash Conversion Cycle Historical Data

The historical data trend for Benchmark Holdings's Cash Conversion Cycle can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Benchmark Holdings Cash Conversion Cycle Chart

Benchmark Holdings Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Cash Conversion Cycle
Get a 7-Day Free Trial Premium Member Only Premium Member Only 83.39 61.87 -7.55 119.90 188.99

Benchmark Holdings Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cash Conversion Cycle Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 132.96 172.62 223.46 210.81 168.16

Competitive Comparison of Benchmark Holdings's Cash Conversion Cycle

For the Drug Manufacturers - Specialty & Generic subindustry, Benchmark Holdings's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Benchmark Holdings's Cash Conversion Cycle Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Benchmark Holdings's Cash Conversion Cycle distribution charts can be found below:

* The bar in red indicates where Benchmark Holdings's Cash Conversion Cycle falls into.



Benchmark Holdings Cash Conversion Cycle Calculation

Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.

Cash Conversion Cycle is one of several measures of management effectiveness.

Benchmark Holdings's Cash Conversion Cycle for the fiscal year that ended in Sep. 2023 is calculated as

Cash Conversion Cycle=Days Sales Outstanding +Days Inventory-Days Payable
=57.42+239.24-107.67
=188.99

Benchmark Holdings's Cash Conversion Cycle for the quarter that ended in Dec. 2023 is calculated as:

Cash Conversion Cycle=Days Sales Outstanding+Days Inventory-Days Payable
=91.57+200.75-124.16
=168.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Benchmark Holdings  (LSE:BMK) Cash Conversion Cycle Explanation

Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.


Be Aware

CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.

The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.


Benchmark Holdings Cash Conversion Cycle Related Terms

Thank you for viewing the detailed overview of Benchmark Holdings's Cash Conversion Cycle provided by GuruFocus.com. Please click on the following links to see related term pages.


Benchmark Holdings (LSE:BMK) Business Description

Traded in Other Exchanges
Address
Yeoman Way, Highdown House, Worthing, West Sussex, GBR, BN99 3HH
Benchmark Holdings PLC is engaged in the healthcare sector. Its operating segment includes Genetics; Advanced Nutrition; Health; and Corporate. The company generates maximum revenue from the Advanced Nutrition segment. The Advanced Nutrition segment manufactures and provides technically advanced nutrition and health products to the aquaculture industry. Geographically, it derives a majority of its revenue from Norway and also has a presence in Vietnam; the Faroe Islands; Ecuador; India; Greece; Canada; Chile, and the Rest of World.

Benchmark Holdings (LSE:BMK) Headlines

No Headlines